Menu
×

Drug Injury

Diabetic Amputation Lawsuit Filed by Invokana User

A diabetic amputation lawsuit says that a drug manufacturer has not gone far enough to warn patients about the risks of losing a limb. The side effect of amputation can drastically alter a patient’s life. Plaintiff Carey L. has initiated the diabetic amputation lawsuit based on allegations that the manufacturer of Invokana failed to warn patients…

Read More

Court Considering Time Limits in Risperdal Breast Growth Cases

The consolidation of Risperdal breast growth cases has now encountered a time limit that could have implications for thousands of different lawsuits that have all been consolidated in Philadelphia against Johnson & Johnson. Recently, the Pennsylvania Supreme Court agreed that in the Risperdal breast growth lawsuits, there must be consideration of when the clock did begin…

Read More

Severe Bleeding from Prompts Legal Claim

A plaintiff has alleged severe bleeding from in a lawsuit against the manufacturer Janssen Research & Development and Johnson & Johnson. Patricia H. says that severe bleeding from developed as a result of taking the drug, but that she was never told about the dangerous risks associated with use of and how it could contribute…

Read More

Invokana Warning Signs Might be Caught Too Late

Those patients who are not aware of the dangers of amputations might not realize the Invokana warning signs that could indicate something serious happening internally. These serious side effects could lead a patient to have a leg or foot amputated. According to the U.S. Food and Drug Administration, Invokana warning signs might not have been…

Read More

Long Term Risperdal Side Effects Could Be Severe

The popular antipsychotic medication has been tied to the risk of long term Risperdal side effects. Long term Risperdal side effects have been reported in adverse patient event reports as well as in academic and medical studies. The long term Risperdal side effects could be especially problematic when they are prescribed to children and young…

Read More

FDA Approves Antidote

A new antidote, AndexXA, has recently been approved as a reversal agent for and Eliquis. Previously, no antidote existed, putting patients at risk of a serious bleeding event. The federal regulators approved the reversal agent after two years of uncertainty and delays. Antidote Could Stop Life-Threatening Bleeds The antidote was called for years ago after…

Read More

Risperdal Lawsuits Surge in Philadelphia Mass Tort

The inventory of Risperdal lawsuits tied to allegations against the manufacturer that patients were never warned about the side effects of the medication, including gynecomastia, have increased dramatically. The pharma related mass tort programs currently being managed in Philadelphia and tied to most Risperdal lawsuits around the country has reached a record high for the…

Read More

IVC Filter Warning Indicates Dangers for Patients

An IVC filter warning issued by the FDA is cause for concern for those patients who have received inferior vena cava filters. These IVC filters are designed to capture blood clots, but may fracture or migrate, according to many IVC filter warnings. New research suggests that the medical community has already started to move away from…

Read More